Managing idiopathic basal ganglia calcification ("Fahr's disease")

Managing Idiopathic Basal Ganglia Calcification ("Fahr's Disease")

Volumn , Issue , 2011, Pages 1-102

  de Oliveira, João Ricardo Mendes ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895282691     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (207)

1. Aboraya A. Scientific Forum on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V)-An Invitation. Psychiatry. 2010; 7(11): 32-6.
2. Achard S, Bullmore E. Efficiency and cost of economical brain functional networks. Plos. Comput. Biol. 2007; 3:174-83.
3. Adachi M, Volk BW. Protracted form of spongy degeneration of the central nervous system (van Bogaert and Bertrand type). Neurology. 1968; 18(11):1084-92.
4. Alemdar M, Selek A, Işeri P, Efendi H, Komsuoǧlu SS. Fahr's disease presenting with paroxysmal non-kinesigenic dyskinesia: a case report. Parkinsonism Relat. Disord. 2008; 14:69-71.
5. Ang LC, Rozdilsky B, Alport EC, Tchang S. Fahr's disease associated with astrocytic proliferation and astrocytoma. Surg. Neurol. 1993; 39(5):365-9.
6. Arenkiel BR, Ehlers MD. Molecular genetics and imaging technologies for circuit-based neuroanatomy. Nature. 2009; 461:900-7.
7. Argyelan M, Carbon M, Niethammer M, Ulug AM, Voss HU, Bressman SB, Dhawan V, Eidelberg D. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J. Neurosci. 2009; 29(31):9740-7.
8. Asensio Moreno C, Arias Jiménez JL, Aramburu Bodas O, Ortega Calvo M, Pérez Cano R. Transient ischemic attack associated with a calcinosis cerebri syndrome. An. Med. Interna. 2008; 25(1):33-5.
9. Avrahami E, Cohn DF, Feibel M, Tadmor R. MRI demonstration and CT correlation of the brain in patients with idiopathic intracerebral calcification. J. Neurol. 1994; 241:381-384.
10. Baba Y, Broderick D, Uitti B, Hutton M, Wszolek Z. Heredofamilial Brain Calcinosis Syndrome. Mayo Clin. Proc. 2005; 80:641-651.
11. Barros e Silva E. [Prevalence analysis of basal ganglia calcification using neuroimaging] Masters dissertation. Federal University of Pernambuco. 2008.
12. Basset DS, Bullmore E. Small-world Brain Networks. The Neuroscientist. 2006; 12:512-23.
13. Beall SS, Patten BM, Mallette L, Jankovic J. Abnormal systemic metabolism of iron, porphyrin, and calcium in Fahr's syndrome. Ann. Neurol. 1989; 26: 569-75.
14. Benke T, Karner E, Seppi K, Delazer M, Marksteiner J, Donnemiller E. Subacute dementia and imaging correlates in a case of Fahr's disease. J. Neurol. Neurosurg. Psychiatry. 2004; 75(8):1163-5.
15. Berendes K, Drstelmann D. Unsuccessful treatment with levodopa of a parkinsonian patient with calcification of the basal ganglia. J. Neurol. 1978; 218: 51-4.
16. Bernal F, Saura J, Ojuel J, Mahy N. Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity. Exp. Neurol. 2000; 161(2): 686-95.
17. Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron. 2010; 68:270-281.
18. Biesecker LG. Exome sequencing makes medical genomics a reality. Nat. Genet. 2010; 42(1):13-4.
19. Bigos KL, Hariri AR. Neuroimaging: technologies at the interface of genes, brain, and behavior. Neuroimaging Clin. N. Am. 2007; 17:459-67.
20. Birchall JD. The interrelationship between silicon and aluminium in the biological effects of aluminium. Ciba Found Symp. 1992; 169: 50-61.
21. Biver F, Goldman S, De Maertelaer V, Luxen A, Mendlewicz J, Lotstra F. Inter-regional correlation of cerebral glucose metabolism in unmedicated schizophrenia. Eur. Neuropsychopharmacol. 1996; 6: 141-147.
22. Biver F, Goldman S, Delvenne V, et al. Altered frontostriatal relationship in unmedicated schizophrenic patients. Psychiatry Res. 1995; 61:161-171.
23. Biver F, Goldman S, Delvenne V, et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol. Psychiatry. 1994; 36:381-388.
24. Boller F, Boller M, Gilbert J. Familial idiopathic cerebral calcifications. J. Neurol. Neurosurg. Psychiatry. 1977; 40:280-285.
25. Braga-Neto UM, Dougherty ER. Bolstered error estimation. Pattern. Recognition. 2004; 37:1267-1281.
26. Braga-Neto UM, Dougherty ER. Classification. In: Edward RD, Ilya S, Jie C, Wang J. Z. Genomic Signal Processing and Statistics. EURASIP Book series on Signal Processing and Communication, Hindawi Publishing Corporation. 2005.
27. Brodaty H, Mitchell P, Luscombe G, Kwok JJ, Badenhop RF et al. Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum. Genet. 2002; 110:8-14.
28. Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009; 10(3):186-98.
29. Callender JS. Non-progressive familial idiopathic intracranial calcification: a family report. J. Neurol. Neurosurg. Psychiatry. 1995; 59(4):432-4.
30. Casamassima F, Lattanzi L, Perlis RH, Fratta S, Litta A, Longobardi A et al. Efficacy of electroconvulsive therapy in Fahr's disease associated with bipolar psychotic disorder: a case report. J. ECT. 2009; 25(3): 213-5.
31. Casanova MF, Araque JM. Mineralization of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Research. 2003; 121(1):59-87.
32. Cavanna AE, Trimble MR. Behavioral correlates of posteromedial parietal cortex hypometabolism in a family with idiopathic basal ganglia calcifications. J. Neurol. Sci. 2008; 266(1-2):190-1.
33. Chen Z, Feng H, Zhu G, Wu N, Lin J. Anomalous intracranial venous drainage associated with basal ganglia calcification. Am. J. Neuroradiol. 2007; 28(1):22-4.
34. Cohen CR, Duchesneau PM, Weinstein MA. Calcification of the basal ganglia as visualized by computed tomography. Radiology. 1980; 134:97-99.
35. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw W J. Gene Expression Profiling of 12633 Genes in Alzheimer Hippocampal CA1: Transcription and Neurotrophic Factor Down-Regulation and Up-Regulation of Apoptotic and Pro-Inflammatory Signaling. Journal of Neuroscience Research. 2002; 70: 462-73.
36. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene Expression Profiling of 12633 Genes in Alzheimer Hippocampal CA1: Transcription and Neurotrophic Factor Down-Regulation and Up-Regulation of Apoptotic and Pro-Inflammatory Signaling. Journal of Neuroscience Research. 2002; 70:462-473.
37. Comtesse N, Niedermayer I, Glass B, Heckel D, Maldener E et al. MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies. Oncogene. 2002; 21(2):239-47.
38. Coppola G, Karydas A, Rademakers R, et al. Gene expression study on peripheral blood identifies progranulin mutations. Ann. Neurol. 2008; 64:92-96.
39. Cummings JL, Gosenfeld LF, Houlihan JP, McCaffrey T. Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol. Psychiatry. 1983; 18: 591-601.
40. Dai X, Gao Y, Xu Z et al. Identification of a novel genetic locus on chromosome 8p21.1-q11.23 for idiopathic basal ganglia calcification. Am J. Med. Genet. B Neuropsychiatr. Genet. 2010; 153:1305-10.
41. Delazer M, Domahs F, Lochy A, Karner E, Benke T, Poewe W. Number processing and basal ganglia dysfunction: a single case study. Neuropsychologia. 2004; 42(8):1050-62.
42. Delgado MR. Reward-related responses in the human striatum. Ann. N. Y. Acad. Sci. 2007; 1104:70-88.
43. Dethy S, Van Blercom N, Damhaut P, Wikler D, Hildebrand J, Goldman S. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism. Mov. Disord. 1998; 13:275-80.
44. Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science. 2009; 323(5920):1473-7.
45. Di YM, Chan E, Wei MQ, Liu JP, Zhou SF. Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes. AAPS J. 2009; 11:469-480.
46. Dorfman R, Nalpathamkalam T, Taylor C et al. Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? Clin. Genet. 2010; 77:464-473.
47. Dowe DA, Heitzman ER, Larkin JJ. Human immunodeficiency virus infection in children. Clin. Imaging. 1992; 16(3):145-51.
48. Dusart I, Marty S, Peschanski M. Glial changes following an excitotoxic lesion in the CNS--II. Astrocytes. Neuroscience. 1991; 45(3): 541-9.
49. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 2009; 32:548-57.
50. Ellie E, Julien J, Ferrer X. Familial idiopathic striopallidodentate calcifications. Neurology. 1989; 39: 381-5.
51. Elsaid MF, Crow YJ, Livingston JH, Ben-Omran T. New subtype of familial intracranial calcification in a mother and two children. Am. J. Med. Genet. A. 2010; 152A (4):943-6.
52. Eskandary H, Sabba M, Khajehpour F, Eskandari M. Incidental findings in brain computed tomography scans of 3000 head trauma patients. Surgical Neurology. 2005; 63: 550-53.
53. Ferrer-Costa C, Gelpí CL, Zamakola L, Parraga I, Cruz X, Orozoco X. PMUT: a web-based tool for the annotation of pathologicalmutation on proteins. Struct. Bioinform. 2005; 21:3176-3178.
54. Forment J, Gilabert F, Robles A, Conejero V, Nuez F, Blanca J M. EST2uni: an open, parallel tool for automated EST analysis and database creation, with a data mining web interface and microarray expression data integration. BMC Bioinformatics. 2008; 7: 9-5.
55. Forment J, Gilabert F, Robles A, Conejero V, Nuez F, Blanca JM. EST2uni: an open, parallel tool for automated EST analysis and database creation, with a data mining web interface and microarray expression data integration. BMC Bioinformatics. 2008; 7: 9-5.
56. Fox A. Computer science. Cloud computing--what's in it for me as a scientist? Science 2011 Jan 28; 331(6016): 406-7.
57. Freudenberg-Hua Y, Freudenberg J, Kluck N, Cichon S, Propping P, Nöthen M. Single Nucleotide Variation Analysis in 65 Candidate Genes For CNS Disorders in a Representative Sample of European Population. Genome Research. 2003; 13: 2271-2276.
58. Fujita D, Terada S, Ishizu H, Yokota O, Nakashima H, et al. Immunohistochemical examination on intracranial calcification in neurodegenerative diseases. Acta Neuropathol. (Berl). 2003; 105(3):259-64.
59. Gavier-Widen D, Wells GA, Simmons MM, Wilesmith JW, Ryan J. Histological observations on the brains of symptomless 7-year-old cattle. J. Comp. Pathol. 2001; 124(1):52-9.
60. Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am. J. Hum. Genet. 1999; 65:764-72.
61. Geschwind DH. Mice, Microarrays, and the genetic diversity of the brain. Pnas. 2000; 97:10676-10678.
62. Goldman S, Amrom D, Szliwowski HB, et al. Reversible striatal hypermetabolism in a case of Sydenham's chorea. Mov. Dis. 1993; 8:355-358.
63. Goldman S, Wetzburger C, Dethy S, Bidaut LM, Stanus E, Luxen A. Frontal lobe glucose hypermetabolism in juvenile Huntington's disease. Neurodegeneration. 1993; 2:165-168.
64. Goodwin RH. Computed tomographic image of Fahr's disease mistaken for acute hemorrhagic cerebrovascular accident. Am. J. Emerg. Med. 2006; 24(3): 378.
65. Grady CL, Keightley ML. Studies of altered social cognition in neuropsychiatric disorders using functional neuroimaging. Can. J. Psychiatry. 2002; 47(4):327-36. Review.
66. Hariri AR, Weinberger DR. Imaging Genomics. Br. Med. Bull. 2003; 65:259-70.
67. Heese K, Akatsu H. Alzheimer's Disease-An Interactive Perspective. Curr. Alzheimer Res. 2006; 2:109-121.
68. Heilig R, Eckenberg R, Petit JL, Fonknechten N, Da Silva C et al. The DNA sequence and analysis of human chromosome 14. Nature. 2003; 421: 601-607.
69. Hempel A, Henze M, Berghoff C, Garcia N, Ody R et al. PET findings and neuropsychological deficits in a case of Fahr's disease. Psychiatry Res. 2001; 108(2): 133-40.
70. Hirota S, Nakajima Y, Yoshimine T, et al. Expression of bone-related protein messenger RNA in human meningiomas: possible involvement of osteopontin in development of psammoma bodies. J. Neuropathol. Exp. Neurol. 1995; 54(5):698-703.
71. Hishikawa N, Hashizume Y, Ujihira N, Okada Y, Yoshida M et al. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification. Neuropathol. Appl. Neurobiol. 2003; 29(3):280-287.
72. Hohmann GF, Wenk GL, Lowenstein P, Brown ME, Coyle JT. Age-related recurrence of basal forebrain lesion-induced cholinergic deficits. Neurosci. Lett. 1987; 82(3): 253-9.
73. Honda T, Fujiwara N, Abe T, Kumanishi T, Yoshimura M, Shimoji K. Prior mechanical injury inhibits rise in intracellular Ca2+ concentration by oxygen-glucose deprivation in mouse hippocampal slices. Brain Res. 1994; 666(2): 263-9.
74. Hu J, Yan C. Identification of deleterious non-synonymous single nucleotide polymorphisms using sequence-derived information. BMC Bioinform. 2008;9:1-8.
75. Kao YC, Lin MI. Intramuscular hemangioma of the temporalis muscle with incidental finding of bilateral symmetric calcification of the basal ganglia: a case report. Pediatr. Neonatol. 2010; 51:296-9.
76. Katscher F. It's Jakob's disease, not Creutzfeldt's. Nature. 1998; 393:11.
77. Kempton MJ, Haldane M, Jogia J, Grasby PM, Collier D, Frangou S. Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar disorder. J. Neurosci. 2009; 29:10863-8.
78. Kerr MK, Churchill GA. Experimental design for gene expression microarrays. Biostatistics. 2001; 2:183-201.
79. Khan SR, Hackett RL. Histochemistry of colloidal iron stained crystal associated material in urinary stones and experimentally induced intrarenal deposits in rats. Scan. Electron. Microsc. 1986; Pt2: 761-5.
80. Kim KM. Apoptosis and calcification. Scanning Microsc 1995; 9:1137-78.
81. Kim S, Dougherty ER, Shmulevich I, et al. Identification of Combination Gene Sets for Glioma Classification. Molecular Cancer Therapeutics. 2002; 1:1229-1236.
82. Klawans HL, Lupton M, Simon L. Calcification of the basal ganglia as a cause of levodopa-resistant parkinsonism. Neurology. 1976; 26: 221-5.
83. Klein C, Vieregge P. The confusing history of 'Fahr's disease'. Neurology. 1998; 50(Suppl. 4):A59.
84. Kotan D, Aygul R. Familial Fahr's disease in a Turkish family. South Med. J. 2009; 102(1):85-86.
85. Kozic D, Todorovic-Djilas L, Semnic R, Miucin-Vukadinovic I, Lucic M. MR imaging-na unreliable and potentially misleading diagnostic modality in patients with intracerebral calcium depositions. Case report. Neuro Endocrinol. Lett. 2009; 30(5): 553-7.
86. Krogias C, Meves S, Schoellhammer M, Gold R, Andrich J. Sonographic detection of bilateral striopallidodentate calcinosis. J. Neurol. 2009; 256(2): 266-7.
87. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and non-parametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 1996; 58:1347-1363.
88. Lam JS, Fong SY, Yiu GC, Wing YK. Fahr's Disease: a differential diagnosis of frontal lobe syndrome. Hong Kong Med. J. 2007;13(1):75-7.
89. Lammie GA, Kelly PAT, Baird JD, Smith W, Chatterjee S, Frier BM, et al. Basal ganglia calcification in BB/E rats with diabetes. Journal of Clinical Neuroscience. 2005; 12(1): 49-53.
90. Langston JW, Sastry S, Chan P, Forno LS, Bolin LM et al. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease. Exp. Neurol. 1998; 154(2):684-90.
91. Larsen TA, Dunn HG, Jan JE, Calne DB. Dystonia and calcification of the basal ganglia. Neurology. 1985; 35:533-537.
92. Le Ber I, Marié RM, Chabot B, Lalevée C, Defer GL. Neuropsychological and 18FDG-PET studies in a family with idiopathic basal ganglia calcifications. J. Neurol. Sci. 2007; 258(1-2):115-22.
93. Lemos RR, Castelletti CH, Lima Filho JL, Marques ET, Oliveira JR. In Silico Identification of New Genetic Variations as Potential Risk Factors for Alzheimer's Disease in a Microarray-oriented Simulation. Journal of Molecular Neuroscience. 2009; 39:242-247.
94. Lemos RR, Oliveira DF, Zatz M, Oliveira JRM. Population and Computational Analysis of the MGEA6 P521A Variation as a Risk Factor for Familial Idiopathic Basal Ganglia Calcification (Fahr's Disease). Journal of Molecular Neuroscience. 2011; 43:333-336.
95. Lester J, Zuniga C, Diaz S, Rugilo C, Micheli F. Diffuse intracranial calcinosis: Fahr's disease. Arch. Neurol. 2006; 63(12): 1806-7.
96. Lhatoo SD, Perunovic B, Love S, Houlden H, Campbell MJ. Familial idiopathic brain calcification-A new and familial alpha-synucleinopathy? Eur. Neurol. 2003; 49:223-226.
97. Limpert J, Liem A, Gabler T, Zellmer H, Tünnermann A, Unger S, et al. High-average-power picosecond Yb-doped fiber amplifier. Opt. Lett. 2001; 26(23):1849-51.
98. Lockhart DJ, Dong H, Byrne MC,et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnology. 1996; 14:1675-1680.
99. Loeb JA, Sohrab SA, Huq M, Fuerst DR. Brain calcifications induce neurological dysfunction that can be reversed by a bone drug. J. Neurol. Sci. 2006;243: 77-81.
100. Loeb JA. Functional improvement in a patient with cerebral calcinosis using a bisphosphonate. Mov. Disord. 1998; 13: 345-9.
101. Lopez-Villegas D, Kulisevsky J, Deus J, Junque C, Pujol J, Guardia E, et al. Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Archs. Neurol. 1996; 53: 251-256.
102. Maetzler W, Berg D, Funke C, Sandmann F, Stünitz H, Maetzler C et al. Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice. Am. J. Pathol. 2010; 177(2): 829-39.
103. Maetzler W, Berg D, Funke C, Sandmann F, Stünitz H, Maetzler C, Nitsch C. Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice. Am. J. Pathol. 2010; 177(2):829-39.
104. Maetzler W, Stünitz H, Bendfeldt K, Vollenweider F, Schwaller B, Nitsch C. Microcalcification after excitotoxicity is enhanced in transgenic mice expressing parvalbumin in all neurones, may commence in neuronal mitochondria and undergoes structural modifications over time. Neuropathol. Appl. Neurobiol. 2009; 35(2): 165-77.
105. Mahlberg R, Walther S, Kalus P, Bohner G, Haedel S, Reischies FM, et al. Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography. Neurobiol. Aging. 2008; 29(2): 203-9.
106. Mahlberg R, Walther S, Kalus P, et al. Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography. Neurobiol. Aging. 2008; 29(2):203-9.
107. Mahy N, Bendahan G, Boatell ML, Bjelke B, Tinner B, Olson L, et al. Differential brain area vulnerability to long-term subcortical excitotoxic lesions. Neuroscience. 1995; 65:15-25.
108. Mahy N, Prats A, Riveros A, Andre's N, Bernal F. Basal ganglia calcification induced by excitotoxicity: an experimental model characterized by electron microscopy and X-ray microanalysis. Acta Neuropathol. 1999; 98(3):217-25.
109. Manyam BV, Walters AS, Keller IA, Ghobrial M. Parkinsonism associated with autosomal dominant bilateral striopallidodentate calcinosis. Parkinsonism Relat. Disord. 2001; 7:289-95.
110. Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov. Disord. 2001; 16(2):258-64.
111. Manyam BV. Bilateral striopallidodentate calcinosis: a proposed classification of genetic and secondary causes. Mov. Disord. 1992; 5:94.
112. Manyam BV. What is and what is not 'Fahr's disease'. Parkinsonism Relat. Disorder. 2005; 11(2):73-80.
113. Matthews WB. Familial calcification of the basal ganglia with response to parathormone. J. Neurol. Neurosurg. Psychiatry. 1957; 20: 172-7.
114. McClellan RL, Eisenberg RL, Giyanani VL. Routine CT screening of psychiatry inpatients. Radiology. 1988; 169(1): 99-100.
115. Miller JA, Oldhan MC, Geschwind DH. A systems level analysis of transcriptional changes in Alzheimer's Disease and normal aging. The Journal Neuroscience. 2008; 28: 1410-20.
116. Mills IG, Sykes RB. Taking risks with translational research. Sci. Transl. Med. 2010 Mar 24; 2(24): 24-10.
117. Modrego PJ, Mojonero J, Serrano M, Fayed N. Fahr's syndrome presenting with pure and progressive presenile dementia. Neurol. Sci. 2005; 26 (5):367-9.
118. Morimoto K, Mogami H, Ozaki K. Fahr's disease associated with cystic astrocytoma. Eur. Neurol. 1984; 23(4):265-8.
119. Moskowitz MA, Winickoff RN, Heinz ER. Familial calcification of the basal ganglia: a metabolic and genetic study. N. Engl. J. Med. 1971; 285:72-7.
120. Munir KM. The treatment of psychotic symptoms in Fahr's disease with lithium carbonate. J. Clin. Psychopharmacol. 1986; 6(1):36-8.
121. Navratil V, Penel S, Delmotte S, Mouchiroud D, Gautier C, Aouacheria A. DigiPINS: A database for vertebrate exonic single nucleotide polymorphisms and its application to cancer association studies. Biochimie. 2008; 90:563-569.
122. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu. Rev. Genomics Hum. Genet. 2006; 7:61-80.
123. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature. 2009; 461: 724-6.
124. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM et al. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010; 42(1): 30-5.
125. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, Cascio D, et al. A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. American Journal of Human Genetics. 2004; 75:822-831.
126. Nitsch C, Scotti A. Ibotenic acid-induced calcium deposits in rat substantia nigra. Ultrastructure of their time-dependent formation. Acta Neuropathol. 1992; 85:55-70.
127. Noppeney U, Friston KJ, Price CJ. Degenerate neuronal systems sustaining cognitive functions. J. Anat. 2004; 205:433-42.
128. Ogi S, Fukumitsu N, Tsuchida D, Uchiyama M, Mori Y, Matsui K. Imaging of bilateral striopallidodentate calcinosis. Clin. Nucl. Med. 2002; 27(10):721.
129. Oliveira J. A new perspective on Human Disorders (http://www.sciencemag. org/content/324/5924/162.2.short/reply#sci_el_12361). Science, Online v. 324,p.162b-162b, 2009.
130. Oliveira JR, de Lemos RR, de Oliveira MF. Updating genetics studies in familial idiopathic basal ganglia calcification. Southern Medical Journal. 2009a; 102:989-989.
131. Oliveira JR, Oliveira MF, Lemos RR, Oliveira ML. The current status of "Fahr's disease" nosology. Practical Neurology. 2009b; 9:302-302.
132. Oliveira JR, Steinberg SS. Far from rare: revisiting the relevance of idiopathic basal ganglia calcifications. Neurol. Sci. 2010; 31(5):665-7.
133. Oliveira JR. Offering unproven genetic tests to the public is irresponsible. Nature. 2008; 456 (7222):570.
134. Oliveira JRM, Hopfer S, Papp J et al. A genome wide scan for familial idiopathic basal ganglia calcification (Fahr's disease) identifies new candidate regions and confirms genetic heterogeneity. Am. J. Hum. Genet. 2003; 5:570.
135. Oliveira JRM, Lemos RR. Linkage studies in familial idiopathic basal ganglia calcification: Separating the wheat from the chaff. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2009; 150:594-95.
136. Oliveira JRM, Lima-Filho JL, Zatz M. Identical twins with Idiopathic Basal Ganglia Calcification (Fahr's Disease) presenting with a remarkably similar pattern of neuroimaging findings. Parkinsonism Relat. Disord. 2009; 15:396-7.
137. Oliveira JRM, Sobrido MJ, Spiteri E, Hopfer S, Meroni G et al. Analysis of Candidate Genes at the IBGC1 Locus Associated with Idiopathic Basal Ganglia Calcification ("Fahr's Disease"). Journal of Molecular Neuroscience. 2007; 33 (2); 151-154.
138. Oliveira JRM, Spiteri E, Sobrido MJ, Hopfer S, Klepper J et al. Genetic heterogeneity in Familial Idiopathic basal Ganglia Calcification ("Fahr's disease"). Neurology. 2004; 63: 2165-2167.
139. Oliveira JRM, Silva EB, Oliveira MF, Castelletti CHM, Lima-Filho JL. The clinical penetrance of idiopathic basal ganglia calcification ("Fahr's Disease"). Neurobiologia. 2008, 71: 86-87.
140. Ones T, Dede F, Gunal D, Ekinci G, Memis H, Erdil TY, et al. The clinical utility of 99mTc-HMPAO SPECT in Fahr's disease. Ann. Nucl. Med. 2008; 22(5):425-8.
141. Ostling S, Andreasson LA, Skoog I. Basal ganglia calcification and psychotic symptoms in the very old. Int. J. Geriatr. Psychiatry. 2003; 18: 983-87.
142. Ott J. Analysis of Human Genetic Linkage. Baltimore, London: Johns Hopkins University Press 1999 (3rd edition).
143. Ott J. Computer-simulation methods in human linkage analysis. Proc. Natl. Acad. Sci. U. S. A. 1989; 86:4175-4178.
144. Ozerov SS, Semenova ZhB, Zubaǐraev MS, Pitskhelauri DI, Ozerova VI, Strebkova NA. Concurrence of Fahr's disease with cerebellar tumors. Zh. Vopr. Neirokhir. Im. N. N. Burdenko. 2004; (4): 34-5.
145. Paschali A, Lakiotis V, Messinis L, Markaki E, Constantoyannis C, Ellul J, et al. Dopamine transporter SPECT/CT and perfusion brain SPECT imaging in idiopathic basal ganglia calcinosis. Clin. Nucl. Med. 2009; 34(7):421-3.
146. Peigneux P, Maquet P, Meulemans T, Destrebecqz A, Laureys S, Degueldre C, et al. Striatum forever, despite sequence learning variability: a random effect analysis of PET data. Hum. Brain Mapp. 2000 Aug; 10(4):179-94.
147. Perez-Iratxeta C, Bork P, Andrade M. Association of genes to genetically inherited diseases using data mining. Nature Genetics. 2002; 31:316-319.
148. Petegnief V, Saura J, Dewar D, Cummins DJ, Dragunow M, Mahy N. Long-term effects of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions. Neuroscience. 1999; 94: 105-115.
149. Picoult-Newberg L, Ideker TE, Pohl MG. et al. Mining SNPs from EST databases. Genome Res. 1999; 9:167-74.
150. Price CJ, Friston KJ. Degeneracy and cognitive anatomy. Trends Cogn. Sci. 2002; 6(10): 416-21.
151. Puvanendran K, Wong PK. Idiopathic familial basal ganglia calcification associated with juvenile hypertension. J. Neurol. Neurosurg. Psychiatry. 1980; 43:288.
152. Ramonet D, Pugliese M, Rodrýguez MJ, De Yebra L, Andrade C, Adroer R, et al. Calcium precipitation in acute and chronic brain diseases. J. Physiol. Paris. 2002; 96:307-312.
153. Ratnaparkhi A, Lawless GM, Schweizer FE, Golshani P, Jackson GR. A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS One. 2008; 3(6): e2334.
154. Rende R, Plomin R. Families at risk for psychopathology: Who becomes affected and why? Development and Psychopathology. 1993; 5: 529-40.
155. Résibois A, Rogers JH. Calretinin in rat brain: an immunohistochemical study. Neuroscience. 1992; 46(1): 101-34.
156. Ring HA, Serra-Mestres J. Neuropsychiatry of the basal ganglia. Journal of Neurol. Neurosurg. Psychiatry. 2002; 72:12-21.
157. Robledo P, Ursu G, Mahy N. Effects of adenosine and gamma-aminobutyric acid A receptor antagonists on N-methyl-D-aspartate induced neurotoxicity in the rat hippocampus. Hippocampus. 1999; 9(5):527-33.
158. Rodrígues MJ, Robledo P, Andrade C, Mahy N. In vivo coordinated interactions between inhibitory systems to control glutamate-mediated hippocampal excitability. J. Neurochem. 2005; 95: 651-61.
159. Rodríguez MJ, Bernal F, Andrés N, Malpesa Y, Mahy N. Excitatory amino acids and neurodegeneration: a hypothetical role of calcium precipitation. Int. J. Dev. Neurosci. 2000; 18(2-3):299-307.
160. Rodríguez MJ, Pugliese M, Mahy N. Drug abuse, brain calcification and glutamate-induced neurodegeneration. Current Drug Abuse Rev. 2009; 2(1):99-112.
161. Saiki M, Saiki S, Sakai K, Matsunari I, Higashi K, Murata KY, et al. Neurological deficits are associated with increased brain calcinosis, hypoperfusion, and hypometabolism in idiopathic basal ganglia calcification. Mov. Disord. 2007; 22(7):1027-30.
162. Sato Y. Basal ganglia calcifications in childhood. Semin. Pediatr. Neurol. 2003; 10:96-1.
163. Saura J, Boatell ML, Bendahan G, Mahy N. Calcium deposit formation and glial reaction in rat brain after ibotenic acid-induced basal forebrain lesion. Eur. J. Neurosci. 1995; 7(7):1569-78.
164. Schadt EE, Linderman MD, Sorenson J, Lee L, Nolan GP. Cloud and heterogeneous computing solutions exist today for the emerging big data problems in biology. Nat. Rev. Genet. 2011;12(3): 224.
165. Schenkman L. Radiology. Second thoughts about CT imaging. Science. 2011; 331(6020):1002-4.
166. Schwarzbraun T, Vincent JB, Schumacher A, et al. Cloning, genomic structure, and expression profiles of TULIP1 (GARNL1), a brain-expressed candidate gene for 14q13-linked neurological phenotypes, and its murine homologue. Genomics. 2004; 84(3):577-86.
167. Scotti G, Scialfa G, Tampieri D, Landoni L. MR imaging in Fahr's disease. J. Comput. Assist. Tomogr. 1985; 9: 790-2.
168. Sentimentale A, Matteoli M, Giovannelli M et al. Fahr's disease detected on a head CT scan in a patient with "epileptic syncope" in the Emergency Department. Intern. Emerg. Medl. 2010; 5:263-265.
169. Shakibai SV, Johnson JP, Bourgeois JA. Paranoid delusions and cognitive impairment suggesting Fahr's disease. Psychosomatics. 2005; 46 (6):569-72.
170. Shirahama M, Akiyoshi J, Ishitobi Y et al. A young woman with visual hallucinations, delusions of persecution and a history of performing arson with possible three-generation Fahr's disease. Acta Psychiatr. Scand. 2010; 121:75-77.
171. Shoyama M, Kitabata Y, Kaku T, Shinosaki K. Evaluation of regional cerebral blood flow in Fahr's disease with schizophrenia-like psychosis: a case report. AJNR Am. J. Neuroradiol. 2005; 26(10):2527-9.
172. Siebner HR, Callicott JH, Sommer T et al. From the genome to the phenome and back: linking genes with human brain function and structure using genetically informed neuroimaging. Neuroscience. 2009; 164:1-6.
173. Sinha R, Sodhi K, John BM, Singh S. Fahr's Disease: A case report. Journal of Nepal Paediatric Society. 2010; 30(1):44-45.
174. Smits MG, Gabreels FJ, Froeling PG, de Abreu RA, Thijssen HO et al. Calcium-phosphate metabolism in autosomal recessive idiopathic strio-pallido-dentate calcinosis and Cockayne's syndrome. Clin. Neurol. Neurosurg. 1983; 85(3):145-153.
175. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker sharing statistics. Am. J. Hum. Genet. 1996; 58:1323-1337.
176. Sobrido MJ, Geschwind DH. Genetics of familial idiopathic basal ganglia calcification (FIBGC). In: Pulst S-M, editor. Genetics of Movement Disorders. San Diego: Academic Press. 2001; 443-448.
177. Sobrido MJ, Hopfer S, Geschwind DH. 2007. Idiopathic basal ganglia calcification. GeneReviews: Genetic Disease Online Reviews. www.geneclinics.org.
178. Souza MBR, Lemos RR, da Cunha JE, de Lima Filho JL, Oliveira JR. Searching for new genetic risk factors for neuropsychiatric disorders in expression databases. J. Mol. Neurosci. 2010; 41(1):193-7.
179. Souza MBR, Lemos RR, Gomes da Cunha JE, Lima Filho JL, Oliveira JRM. Searching for New Genetic Risk Factors for Neuropsychiatric Disorders in Expression Databases. Journal of Molecular Neuroscience. 2010; 41:193-197.
180. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008; 455:232-236.
181. Stein LD. Towards a cyberinfrastructure for the biological sciences: progress, visions and challenges. Nat. Rev. Genet. 2008; 9: 678-88.
182. Stopczynski RE, Poloskey SL, Haber SN. Cell proliferation in the striatum during postnatal development: preferential distribution in subregions of the ventral striatum. Brain Struct. Function. 2008; 213:119-127.
183. Sudol M, Krzystof S, Russo T. Functions of WW domains in the nucleus. FEBS Letters. 2001; 490:190-195.
184. Tanabe Y, Ishizu H, Ishiguro K, Itoh N, Terada S et al. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation. Neuroreport. 2000; 11(11): 2473-2477.
185. Terada S, Ishizu H, Tanabe Y, Takehisa Y, Haraguchi T, Hamaya K, Nose S, Sudo K, Kuroda S. Plaque-like structures and arteriosclerotic changes in "diffuse neurofibrillary tangles with calcification" (DNTC). Acta Neuropathol. (Berl). 2001; 102(6):597-603.
186. Towfighi J, Yager JY, Housman C, Vannucci RC. Neuropathology of remote hypoxic-ischemic damage in the immature rat. Acta Neuropathol. 1991; 81(5): 578-87.
187. Tu PH, Galvin JE, Baba M, Giasson B, Tomita T et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple-system atrophy brains containing insoluble alpha-synuclein. Ann. Neurol. 1998; 44(3):415-22.
188. Useche FJ, Gao G, Hanafey M, Rafalski A. High-Throughput Identification, Database Storage and Analysis of SNPs in EST Sequences. Genome Informatics. 2001; 12:194-203.
189. Uygur GA, Liu Y, Hellman RS, Tikofsky RS, Collier BD. Evaluation of regional cerebral blood flow in massive intracerebral calcifications. J. Nucl. Med. 1995; 36:610-612.
190. Vahedi P, Mohajernezhad Z, Zeinali A, Pourakbar E. Fahr Syndrome, A Rare Neurodegenerative Disorder. Neurosurgery Quarterly. 2009; 9(1): 69-71.
191. Van Bogaert P, Massager N, Tugendhaft P, et al. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage. 2000;12(2):129-38.
192. van't Ent D, van Beijsterveldt CEM, Derks EM et al. Neuroimaging of response interference in twins discordant or concordant for inattention and hyperactivity symptoms. Neuroscience. 2009; 164:16-29.
193. Volpato CB, De Grandi A, Buffone E, Facheris M, Gebert U, Schifferle G, et al. 2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family. J. Mol. Neurosci. 2009; 39(3):346-53.
194. Walsh T, Mcclellan JM, Mccarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008; 320:539-543.
195. Weisman DC, Yaari R, Hansen LA, Thal LJ. Density of the brain, decline of the mind: an atypical case of Fahr disease. Arch. Neurol. 2007; 64(5):756-7.
196. Wider C, Dickson DW, Schweitzer KJ et al. Familial idiopathic basal ganglia calcification: a challenging clinical-pathological correlation. Journal of Neurology. 2009; 256:839-842.
197. Wszolek ZK, Baba Y, Mackenzie IR, et al. Autosomal dominant dystonia-plus with cerebral calcifications. Neurology. 2006; 67(4):620-5.
198. Wszolek, ZK, Tsuboi Y, Broderick DF, et al. Large family with segmental dystonia-plus and cerebral calcinosis-possible linkage to chromosome 8 [abstract]. Neurology. 2003; 60(suppl 1):A272.
199. Yanai T, Masegi T, Ishikawa K, Sakai H, Iwasaki T, Moritomo Y, et al. Spontaneous vascular mineralization in the brain of horses. J. Vet. Med. Sci. 1996; 58(1):35-40.
200. Yanai T, Masegi T, Ueda K, Manabe J, Teranishi M, Takaoka M, Matsunuma N, Fukuda K, Goto N, Fujiwara K. Vascular mineralization in the monkey brain. Vet. Pathol. 1994; 31(5):546-52.
201. Yasui M, Yano I, Tsuda T, Ota K. [Effects of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (bifemelane) on deposition of calcium and magnesium in the central nervous system tissues of rats maintained on low-calcium diets]. No To Shinkei. 1991; 43(12): 1133-7.
202. Yasui N, Sato M, Ochi T, Kimura T, Kawahata H, Kitamura et al. Three modes of ossification during distraction osteogenesis in the rat. J. Bone Joint Surg. Br. 1997; 79(5): 824-30.
203. Yokota O, Terada S, Ishizu H, Tsuchiya K, Kitamura Y et al. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC). Acta Neuropathol. 2002; 104(4):333-41.
204. Yoshikawa H, Abe T. Transient parkinsonism in bilateral striopallidodentate calcinosis. Pediatr. Neurol. 2003; 29(1):75-77.
205. Yu CE, Dawson G, Munson J, et al. Presence of large deletions in kindreds with autism. American Journal of Human Genetics. 2002; 71:100-115.
206. Yulug B. A Case of Idiopathic Basal Ganglia Calcification Presenting With Only Acting-Out Attacks and Mild Cognitive Impairment: PET Findings. J. Neuropsychiatry Clin. Neurosci. 2007, 19 (3): 348-349.
207. Zarrinpar A, Bhattacharyya RP, Lim WA. The structure of proline recognition domains. Sci. STKE. 2003; 22:1-10.